Merck
MRK
#40
Rank
HK$2.785 T
Marketcap
HK$1,130
Share price
-0.29%
Change (1 day)
56.59%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): HK$7.73

According to Merck's latest financial reports the company's current EPS (TTM) is HK$7.79. In 2025 the company made an earnings per share (EPS) of HK$57.36 an increase over its 2024 EPS that were of HK$53.03.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$7.73-86.53%
2025HK$57.368.15%
2024HK$53.034308.46%
2023HK$1.20-97.32%
2022HK$44.9610.92%
2021HK$40.5384.68%
2020HK$21.95-27.2%
2019HK$30.1563.44%
2018HK$18.44151.11%
2017HK$7.35-54.58%
2016HK$16.1730.21%
2015HK$12.42-61.99%
2014HK$32.67180.51%
2013HK$11.65-31.82%
2012HK$17.086.62%
2011HK$16.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41 572.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.19 428.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-28.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$21.21 172.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.36 3,010.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.36 1,650.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.54 99.44%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$35.46 355.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.58 189.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$3.53-54.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel